Joel Sendek
2017
In 2017, Joel Sendek earned a total compensation of $1.2M as Chief Financial Officer at Spero Therapeutics.
Compensation breakdown
| Bonus | $67,912 |
|---|---|
| Option Awards | $905,464 |
| Salary | $236,667 |
| Other | $312 |
| Total | $1,210,355 |
Sendek received $905.5K in option awards, accounting for 75% of the total pay in 2017.
Sendek also received $67.9K in bonus, $236.7K in salary and $312 in other compensation.
Rankings
In 2017, Joel Sendek's compensation ranked 8,063rd out of 14,666 executives tracked by ExecPay. In other words, Sendek earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,063 out of 14,666 | 45th |
Division Manufacturing | 3,036 out of 5,772 | 47th |
Major group Chemicals And Allied Products | 999 out of 2,075 | 52nd |
Industry group Drugs | 782 out of 1,731 | 55th |
Industry Pharmaceutical Preparations | 617 out of 1,333 | 54th |
Source: SEC filing on April 27, 2018.
Sendek's colleagues
We found three more compensation records of executives who worked with Joel Sendek at Spero Therapeutics in 2017.